Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1989-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.86.5.1657PMID 2493647PMCID PMC286758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of fibroblast cyclooxygenase synthesis by interleukin-1.

  1988cited by this paper
• Interferon-gamma-induced transcriptional activation is mediated by protein kinase C.

  1988cited by this paper
• Inhibition by corticosteroids of epidermal growth factor‐induced recovery of cyclooxygenase after aspirin inactivation

  1988cited by this paper
• Human calpactin II (lipocortin I) messenger ribonucleic acid is not induced by glucocorticoids.

  1988cited by this paper
• Lipocortin and the mechanism of action of the glucocorticoids

  1988cited by this paper
• Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.

  1987cited by this paper
• Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblasts: evidence for G protein regulation of phospholipase A2.

  1987cited by this paper
• Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent

  1987cited by this paper
• The diacylglycerols dioctanoylglycerol and oleoylacetylglycerol enhance prostaglandin synthesis by inhibition of the lysophosphatide acyltransferase.

  1987cited by this paper
• sn-1,2-Diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells.

  1987cited by this paper
• Evidence of protein kinase C involvement in phorbol diester-stimulated arachidonic acid release and prostaglandin synthesis.

  1987cited by this paper
• Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2.

  1986cited by this paper
• Phorbol ester induces c-sis gene transcription in stem cell line K-562

  1986cited by this paper
• Studies and perspectives of protein kinase C.

  1986cited by this paper
• Paradoxical conservation of cardiac and renal arachidonate content in essential fatty acid deficiency.

  1985cited by this paper
• Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1.

  1985cited by this paper
• Hydrocortisone inhibits prostaglandin production but not arachidonic acid release from cultured macrophages

  1984cited by this paper
• Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

  1984cited by this paper
• Mechanism of enhanced fibroblast arachidonic acid metabolism by mononuclear cell factor.

  1984cited by this paper
• Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene

  1984cited by this paper
• Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

  1983cited by this paper
• Dexamethasone-induced inhibition of prostaglandin production dose not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor.

  1982cited by this paper
• Anti-inflammatory steroids reduce tissue PG synthetase activity and enhance PG breakdown

  1980cited by this paper
• Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate.

  1979cited by this paper

• EVALUATION OF ASPIRIN RESPONSIVENESS IN ESSENTIAL THROMBOCYTHEMIA PATIENTS

  2018cites this paper
• Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy

  2018cites this paper
• INHIBITION OF COX-2 ENZYME BY THE VARIOUS EXTRACTS OF ANTI-INFLAMMATORY ACTIVITY IN ALBINO RAT

  2017cites this paper
• TLR2 Receptor Activation and COX-2 Upregulation in Airway Smooth Muscle Cells: Uncovering the Molecular Mechanisms

  2016cites this paper
• Post-transcriptional Mechanisms in Endocrine Regulation

  2016cites this paper
• Prostaglandin Synthase-Mediated Metabolism of Carcinogens and a Potential Role for Peroxyl Radicals As Reactive

  2016cites this paper
• Cyclooxygenase 2: its regulation, role and impact in airway inflammation

  2016cites this paper
• Post-transcriptional Regulation of Prostaglandin Biosynthesis

  2016cites this paper
• Management of Hyperuricemia and Gout

  2013cites this paper
• Pathogenesis of Pseudophakic Cystoid Macular Oedema

  2012cites this paper
• NEW INSIGHTS INTO CYCLOOXYGENASE ISOFORMS AND CANCER TREATMENT: CYCLOOXYGENASE-2 INHIBITION - A PROMISING STRATEGY

  2011cites this paper
• Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study

  2010cites this paper
• A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation

  2010cites this paper
• Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy

  2009cites this paper
• Cyclooxygenase-2 inhibitors and knee prosthesis surgery

  2008cites this paper
• Identification of a key regulatory pathway in bone regeneration using a novel mouse fracture model

  2007cites this paper
• CANCER DRUG DISCOVERY AND DEVELOPMENT

  2007cites this paper
• Successful treatment of cystoid macular edema with valdecoxib

  2007cites this paper
• Current status and future perspectives of chemoprevention in head and neck cancer.

  2007cites this paper
• Novel cyclooxygenase‐catalyzed bioactive prostaglandin F2α from physiology to new principles in inflammation

  2007cites this paper
• COX-2 inhibitors and cardiovascular risk.

  2007cites this paper
• Cyclooxygenase: Past, present and future. A tribute to John R. Vane (1927–2004)

  2006cites this paper
• Dexamethasone Impairs the Gastric Mucosal Integrity in Rats Treated with a Cyclooxygenase-1 but Not with a Cyclooxygenase-2 Inhibitor

  2006cites this paper
• Mechanism of 12-0-Tetradecanoylphorbol-13-acetate Enhanced Metabolism of Arachidonic Acid in Dog Urothelial Cells1

  2006cites this paper
• Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing

  2006cites this paper
• Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system.

  2006cites this paper
• Experimental study of the action of COX-2 selective nonsteroidal anti-inflammatory drugs and traditional anti-inflammatory drugs in bone regeneration.

  2006cites this paper
• Cyclooxygenase-2-specific Inhibitor Improves Functional Outcomes, Provides Neuroprotection, and Reduces Inflammation in a Rat Model of Traumatic Brain Injury

  2005cites this paper
• Structural and functional differences between cyclooxygenases: fatty acid oxygenases with a critical role in cell signaling.

  2005cites this paper
• Cyclooxygenase-2 inhibitors: a new therapeutic option in the treatment of macular edema after cataract surgery.

  2005cites this paper
• Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.

  2005cites this paper
• La innovación farmacéutica. Comentarios sobre tres noticias

  2005cites this paper
• Analgesic efficacy of preoperative parecoxib sodium in an orthopedic pain model.

  2004cites this paper
• Characterisation of a novel variant in the human cyclooxygenase-2 gene : implications for fibrotic lung disease and inflammation.

  2004cites this paper
• Dysregulated post-transcriptional control of COX-2 gene expression in cancer.

  2004cites this paper
• Interaction of inducible nitric oxide synthase and cyclooxygenase-2 inhibitors in formalin-induced nociception in mice.

  2004cites this paper
• Interaction of Cyclooxygenase Isoenzymes, Nitric Oxide, and Afferent Neurons in Gastric Mucosal Defense in Rats

  2004cites this paper
• Comparación de Parecoxib vs Diclofenac en el manejo del dolor postoperatorio y requerimiento de opioide en apendicectomias y colecistectomias en el Hospital Militar Central

  2004cites this paper
• [Specific cyclooxygenase-2 inhibitor analgesics: therapeutic advances.].

  2004cites this paper
• Analgésicos inibidores específicos da ciclooxigenase-2: avanços terapêuticos

  2004cites this paper
• The mechanism of action of aspirin

  2003cites this paper
• Regulation of COX-2 expression in human cancers.

  2003cites this paper
• Historical Aspects of COX-2

  2003cites this paper
• The development of COX2 inhibitors

  2003cites this paper
• The mechanism of action of aspirin.

  2003influential citation
• The mechanism of action of anti-inflammatory drugs.

  2003cites this paper
• Protein regulators of eicosanoid synthesis: role in inflammation.

  2002cites this paper
• Cyclooxygenase Inhibitor, a Foe or a Friend in the Mucosal Protection and Repair

  2002cites this paper
• COX-2: a target for colon cancer prevention.

  2002cites this paper
• Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2.

  2002cites this paper
• Modeling and biological evaluation of 3,3'-(1,2-ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor.

  2002cites this paper
• Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat.

  2002cites this paper
• Up-regulation of Cyclooxygenase-2 Expression and Prostaglandin Synthesis in Endometrial Stromal Cells by Malignant Endometrial Epithelial Cells

  2002cites this paper
• Attenuation of pro-inflammatory neuropeptide levels produced by a cyclooxygenase-2 inhibitor in an animal model of chronic temporomandibular joint inflammation.

  2002cites this paper
• Valdecoxib, a COX-2–Specific Inhibitor, Is an Efficacious, Opioid-Sparing Analgesic in Patients Undergoing Hip Arthroplasty

  2002cites this paper
• Prostaglandins and cystoid macular edema.

  2002cites this paper
• Cox-2-specific inhibitors: definition of a new therapeutic concept.

  2001cites this paper
• Effects of specific inhibition of cyclo‐oxygenase‐1 and cyclo‐oxygenase‐2 in the rat stomach with normal mucosa and after acid challenge

  2001cites this paper
• Role of cyclooxygenase isoforms in gastric mucosal defence.

  2001cites this paper
• Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion.

  2001cites this paper
• Cyclooxygenase 2—implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives

  2001cites this paper
• Neural aspects of prostaglandin involvement in gastric mucosal defense.

  2001cites this paper
• Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.

  2001cites this paper
• Role of cyclooxygenase-2 in gastric mucosal defense.

  2001cites this paper
• Inflammation, carcinogenesis and cancer.

  2001cites this paper
• Cyclooxygenase-2 inhibitors.

  2001cites this paper
• Perforated gastric ulcer complicating corticosteroid therapy in acute rheumatic fever.

  2000cites this paper
• Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial.

  2000cites this paper
• Aspirin and other anti-inflammatory drugs

  2000cites this paper
• Significant upper gastrointestinal events associated with conventional NSAID versus celecoxib.

  2000cites this paper
• Cyclooxygenase-2 in synovial tissue and fluid of dysfunctional temporomandibular joints with internal derangement.

  2000cites this paper
• The fight against rheumatism: from willow bark to COX-1 sparing drugs.

  2000cites this paper
• Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease.

  2000cites this paper
• Prostaglandins and inflammation: the cyclooxygenase controversy.

  2000cites this paper
• Spatial Requirements for 15-(R)-Hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic Acid Synthesis within the Cyclooxygenase Active Site of Murine COX-2

  2000cites this paper
• Selective Inhibitors of COX-2 - Are They Safe for the Stomach?

  2000cites this paper
• Dietary oxidized oil influences the levels of type 2 T-helper cell-related antibody and inflammatory mediators in mice.

  2000cites this paper
• Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents.

  2000cites this paper
• Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.

  2000cites this paper
• Role of prostaglandin E₂ in the pathogenesis of pulmonary fibrosis.

  2000cites this paper
• Post-transcriptional Control of Cyclooxygenase-2 Gene Expression

  2000cites this paper
• Studies on Cyclooxygenase-2 Expression in Lipopolysaccharide-Stimulated Macrophages.

  1999cites this paper
• COX-2: separating myth from reality.

  1999cites this paper
• Cyclooxygenases in Reproductive Medicine and Biology

  1999cites this paper
• Regulatory effects of HDL on smooth muscle cell prostacyclin release.

  1999cites this paper
• Interactions between the inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) pathways: implications for therapeutic intervention in osteoarthritis.

  1999cites this paper
• Selective cyclooxygenase-2 inhibitors.

  1999cites this paper
• The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.

  1999cites this paper
• Cyclooxygenases in reproductive medicine and biology.

  1999cites this paper
• Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis.

  1999cites this paper
• Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology.

  1999cites this paper
• Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed?

  1999cites this paper
• Selective cyclo‐oxygenase‐2 inhibitors aggravate ischaemia‐reperfusion injury in the rat stomach

  1999cites this paper
• Overview of COX-2 in inflammation: from the biology to the clinic

  1999cites this paper
• Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

  1999cites this paper
• On the role of PGD2 metabolites as markers of mast cell activation in asthma.

  1999cites this paper
• Selective COX-2 Inhibitors

  1998cites this paper
• Roles of COX-1 and COX-2 in gastrointestinal pathophysiology

  1998cites this paper
• Mechanism of action of anti-inflammatory drugs: an overview

  1998cites this paper
• Differential inhibition of cyclooxygenase isoforms: an explanation of the action of NSAIDs.

  1998cites this paper